Please do not leave this page until complete. This can take a few moments.
Massachusetts marijuana company Curaleaf, with its cultivation and manufacturing facility in Webster, has been warned by the U.S. Food and Drug Administration for illegally selling CBD online and claiming that products treat cancer, Alzheimer’s, opioid withdrawal, pain and pet anxiety.
According to the FDA, the Wakefield-headquartered company claims CBD has been found to counteract the spread of cancer, treat Pakrinson’s disease, treat anxiety, and help calm dogs.
CBD -- or cannabidiol -- is the non-psychoactive chemical in cannabis or hemp some say can help treat some ailments. Its legal status remains unclear even after Congress legalized hemp last year.
“As we examine potential regulatory pathways for the lawful marketing of products containing cannabis and cannabis-derived compounds like CBD, protecting and promoting public health remains our top priority,” the FDA said in a statement. “Selling unapproved products with unsubstantiated therapeutic claims — such as claims that CBD products can treat serious diseases and conditions — can put patients and consumers at risk by leading them to put off important medical care.”
The agency has requested a response from Curaleaf within 15 working days stating how the company will correct the alleged violations.
With CBD becoming increasingly popular and CBD and other cannabis products not yet subject to FDA approval, the FDA wants companies to be cautious in making claims not backed by the FDA.
“Unsubstantiated claims associated with CBD products may lead consumers to put off getting important medical care, such as proper diagnosis, treatment and supportive care,” the agency said.
The company could not immediately be reached for comment.
Curaleaf is one of the largest cannabis firms in the country with a significant portion of its Massachusetts operations in Central Massachusetts.
Its cultivation and manufacturing facility is located in Webster and a medical dispensary is open in Oxford.
Other dispensaries are planned for Ware and Provincetown.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments